Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christian Marth

Showing results (91-100 of 237) with videos related to

Pageof 24
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 4, 2007
Clinical relevance of E2F family members in ovarian cancer--an evaluation in a training set of 77 patientsDaniel Reimer, Susann Sadr, Annemarie Wiedemair, et al.
Frontiers in Oncology|September 17, 2025
Are brain metastases a special issue in POLE-mutated endometrial cancer? a case report seriesChristoph Ebner, Kristina Lindemann, Gunnar Kristensen, et al.
International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics|June 10, 2025
Mid-trimester patch repair of a large cesarean scar dehiscence in an incarcerated gravid uterus with successful pregnancy outcome - A case report and review of literatureElisabeth D'Costa, Irene Mutz-Dehbalaie, Mara Mantovan, et al.
Frontiers in Oncology|September 26, 2022
A comparison of four technologies for detecting p53 aggregates in ovarian cancerNicole Heinzl, Katarzyna Koziel, Elisabeth Maritschnegg, et al.
International Journal of Cancer|December 5, 2019
High RIG-I expression in ovarian cancer associates with an immune-escape signature and poor clinical outcomeDominik Wolf, Heidi Fiegl, Alain G Zeimet, et al.
Gynecologic Oncology|April 22, 2004
Methylation status and expression of human telomerase reverse transcriptase in ovarian and cervical cancerAndreas Widschwendter, Hannes M Müller, Michael M Hubalek, et al.
International Journal of Cancer|December 2, 2017
Truncated isoform Vav3.1 is highly expressed in ovarian cancer stem cells and clinically relevant in predicting prognosis and platinum-responseDaniel Reimer, Maximilian Boesch, Dominik Wolf, et al.
Wiener Klinische Wochenschrift|November 13, 2010
Clinical consequences of the Calypso trial showing superiority of PEG-liposomal doxorubicin and carboplatin over paclitaxel and carboplatin in recurrent ovarian cancer: results of an Austrian gynecologic oncologists' expert meetingEdgar Petru, Alexander Reinthaller, Lukas Angleitner-Boubenizek, et al.
Anticancer Research|February 6, 2009
Erythropoetin beta twice weekly versus standard therapy in patients with gynaecological malignancies--a randomised Austrian AGO trialBirgit Volgger, Edgar Petru, Lukas Angleitner-Boubenizek, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|September 10, 2002
Mammaglobin expression in gynecologic malignancies and malignant effusions detected by nested reverse transcriptase-polymerase chain reactionKurt Grünewald, Margot Haun, Michael Fiegl, et al.
Pageof 24

Showing results (91-100 of 237) with videos related to

Sort By:
Pageof 24
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 4, 2007
Clinical relevance of E2F family members in ovarian cancer--an evaluation in a training set of 77 patientsDaniel Reimer, Susann Sadr, Annemarie Wiedemair, et al.
Frontiers in Oncology|September 17, 2025
Are brain metastases a special issue in POLE-mutated endometrial cancer? a case report seriesChristoph Ebner, Kristina Lindemann, Gunnar Kristensen, et al.
International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics|June 10, 2025
Mid-trimester patch repair of a large cesarean scar dehiscence in an incarcerated gravid uterus with successful pregnancy outcome - A case report and review of literatureElisabeth D'Costa, Irene Mutz-Dehbalaie, Mara Mantovan, et al.
Frontiers in Oncology|September 26, 2022
A comparison of four technologies for detecting p53 aggregates in ovarian cancerNicole Heinzl, Katarzyna Koziel, Elisabeth Maritschnegg, et al.
International Journal of Cancer|December 5, 2019
High RIG-I expression in ovarian cancer associates with an immune-escape signature and poor clinical outcomeDominik Wolf, Heidi Fiegl, Alain G Zeimet, et al.
Gynecologic Oncology|April 22, 2004
Methylation status and expression of human telomerase reverse transcriptase in ovarian and cervical cancerAndreas Widschwendter, Hannes M Müller, Michael M Hubalek, et al.
International Journal of Cancer|December 2, 2017
Truncated isoform Vav3.1 is highly expressed in ovarian cancer stem cells and clinically relevant in predicting prognosis and platinum-responseDaniel Reimer, Maximilian Boesch, Dominik Wolf, et al.
Wiener Klinische Wochenschrift|November 13, 2010
Clinical consequences of the Calypso trial showing superiority of PEG-liposomal doxorubicin and carboplatin over paclitaxel and carboplatin in recurrent ovarian cancer: results of an Austrian gynecologic oncologists' expert meetingEdgar Petru, Alexander Reinthaller, Lukas Angleitner-Boubenizek, et al.
Anticancer Research|February 6, 2009
Erythropoetin beta twice weekly versus standard therapy in patients with gynaecological malignancies--a randomised Austrian AGO trialBirgit Volgger, Edgar Petru, Lukas Angleitner-Boubenizek, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|September 10, 2002
Mammaglobin expression in gynecologic malignancies and malignant effusions detected by nested reverse transcriptase-polymerase chain reactionKurt Grünewald, Margot Haun, Michael Fiegl, et al.
Pageof 24